Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome by Satoshi Saida, Ken-ichiro Watanabe, Aiko Sato-Otsubo, Kiminori Terui, Kenichi Yoshida, Yusuke Okuno, Tsutomu Toki, RuNan Wang, Yuichi Shiraishi, Satoru Miyano, Itaru Kato, Tatsuya Morishima, Hisanori Fujino, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi, Etsuro Ito, Seishi Ogawa, Mamoru Ito, Tatsutoshi Nakahata, and Toshio Heike Blood Volume 121(21):4377-4387 May 23, 2013 ©2013 by American Society of Hematology TAM cells engrafted in NOG mice. Satoshi Saida et al. Blood 2013;121:4377-4387 ©2013 by American Society of Hematology The NOG mouse model can support self-renewal of TAM-derived cells. Satoshi Saida et al. Blood 2013;121:4377-4387 ©2013 by American Society of Hematology Sequential CNA analysis of TAM-derived cells in the recipients of patient 1. Satoshi Saida et al. Blood 2013;121:4377-4387 ©2013 by American Society of Hematology TAM-derived cells show genetic and functional diversity. Satoshi Saida et al. Blood 2013;121:4377-4387 ©2013 by American Society of Hematology A minor subclone with additional CNAs was present in the primary TAM patient sample, whereas a new clone emerged in a 1° recipient. Satoshi Saida et al. Blood 2013;121:4377-4387 ©2013 by American Society of Hematology Serial transplantation and CNA profiling of TAM-derived cells from patients that did not develop ML-DS. Satoshi Saida et al. Blood 2013;121:4377-4387 ©2013 by American Society of Hematology